HFA Premium Access

Diagnosing heart failure with preserved ejection fraction in patients with unexplained dyspnea using exercise echocardiography: impact of different diagnostic thresholds

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Congress Presentation

About the speaker

Assistant Professor Andreas Bernard Gevaert

University of Antwerp, Antwerp (Belgium)
5 presentations
0 follower

7 more presentations in this session

Safety and clinical effects of sodium-glucose cotransporter-2 inhibitors in transthyretin amyloid cardiomyopathy

Speaker: Doctor A. Nalbandian (New York, US)


Impact of temporary LV systolic dysfunction on long-term clinical outcome in patients with preserved ejection fraction after acute myocardial infarction

Speaker: Doctor J. Kim (Seoul, KR)


Vascular stiffness, cardiac chamber stiffness and cardiovascular risk factors in women versus men with pre-HFpEF; a report from the PARABLE trial.

Speaker: Doctor B. Wong (Dublin, IE)


Left-to-right ventricular volume ratio and outcome in heart failure with preserved ejection fraction

Speaker: Doctor A. Aimo (Pisa, IT)


Coronary microvascular dysfunction, central and overall obesity and metabolic and fibrotic biomarkers in patients with heart failure with preserved ejection fraction (data from PROMIS-HFpEF)

Speaker: Mr M. Erhardsson (Stockholm, SE)


Access the full session

Heart failure with preserved ejection fraction (HFpEF) 1

Speakers: Assistant Professor A. Gevaert, Doctor A. Nalbandian, Doctor J. Kim, Doctor B. Wong, Doctor A. Aimo...

About the event


Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb